Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder.

Journal of cancer research and clinical oncology - 1 Sept 2017

Hess Jochen, Stelmach Patrick, Eisenhardt Andreas, Rübben Herbert, Reis Henning, Schmid Kurt Werner, Bachmann Hagen Sjard

Abstract excerpt

PURPOSE: To evaluate the impact of three BCL2 single-nucleotide polymorphisms, i.e., c.-938C>A (rs2279115), c.21G>A (rs1801018), and c.*2203A>G (rs4987853) on survival in patients with transitional cell carcinoma of the bladder. METHODS: We analyzed 179 patients who underwent surgical treatment for bladder cancer at the Clinic of Urology, University Hospital Essen, Germany. Genomic DNA was extracted and genotyped...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Carcinoma, Transitional Cell
Share to Disease-Free Survival
Share to Kaplan-Meier Estimate
Share to Proportional Hazards Models
Share to Proto-Oncogene Proteins c-bcl-2
Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 28417194
DOI: 10.1007/s00432-017-2404-8

Genes

BCL2

Variants

rs2279115

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder.PMID 28417194Read ↗

The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.Semantic proximity Read ↗

Role of Bcl-2 -938 C>A polymorphism in susceptibility and prognosis of cancer: a meta-analysis.Semantic proximity Read ↗

The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma.Semantic proximity Read ↗

BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients.Semantic proximity Read ↗

BCL2 genotypes and prostate cancer survival.Semantic proximity Read ↗

Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.Semantic proximity Read ↗

Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.Semantic proximity Read ↗

BH3 domain mutation of proapoptotic genes Bad, Bmf and Bcl-G is rare in transitional cell carcinomas of the urinary bladder.Semantic proximity Read ↗

Association of the AA genotype of the BCL2 (-938C>A) promoter polymorphism with better survival in ovarian cancer.Semantic proximity Read ↗

Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma.Semantic proximity Read ↗

BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia.Semantic proximity Read ↗

Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.